WHWillem Huisman

Willem Huisman

*This is an algorithmically generated author record based on publicly available information.

Willem Huisman has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Grupo de Trabajo de la EFLM sobre Acreditación y Normas ISO/CEN sobre cómo abordar los requisitos de la norma ISO15189 sobre retención de documentación y muestras

    by Pika Meško Brguljan, Marc H.M. Thelen, Francisco A. Bernabeu-Andreu, Christos Kroupis, Guilaine Boursier, Ines Vukasović, Edward Barrett, Duilio Brugnoni, Maria Lohmander, Luděk Šprongl, et al.

    Resumen: Gran parte de la actividad en el laboratorio clínico debe quedar documentada para facilitar el mantenimiento de la calidad del servicio, lo que deriva en la generación de una gran cantidad de documentación, formularios e informes. Con tal objeto, es necesario especificar el tiempo de retención requerido para cada tipo de documento y muestra. Además de la obligación de conservar los informes del laboratorio clínico como parte de la historia clínica de los pacientes, el laboratorio también está obligado por ley, o según las directrices de las organizaciones profesionales, si las hubiera, a retener un gran volumen de documentación y muestras. En caso contrario, la dirección del laboratorio deberá establecer un calendario de retención, en el que se especifiquen las condiciones y el periodo de conservación, de acuerdo con los requisitos de la norma ISO 15189:2022 sobre retención de documentación y registros de gestión de la calidad. En el presente proyecto, el Grupo de Trabajo de la EFLM sobre Acreditación y Normas ISO/CEN propone una serie de periodos de retención de documentación y muestras, basada en la metodología de análisis modal de fallos y efectos (AMFE), un método para la reducción de riesgos que ha pasado a formar parte integral de los estándares actuales.


  • Open Access

    EFLM Working Group Accreditation and ISO/CEN standards on dealing with ISO 15189 demands for retention of documents and examination objects

    by Pika Meško Brguljan, Marc H. M. Thelen, Francisco A. Bernabeu-Andreu, Christos Kroupis, Guilaine Boursier, Ines Vukasović, Edward Barrett, Duilio Brugnoni, Maria Lohmander, Luděk Šprongl, et al.

    Many aspects of the activity of a medical laboratory have to be documented so as to facilitate the maintenance of the ongoing quality of service. As a consequence, many documents, forms and reports are generated. The retention time for each of these has to be specified. In addition to medical laboratory reports as part of the patient’s medical record, the medical laboratory has to retain many documents and specimens according to national legislation or guidance from professional organizations, if these exist. If not, the laboratory management needs to define a retention schedule, which shall define the storage conditions and period of storage, according to ISO 15189:2022 requirements for retention of general quality management documents and records. The EFLM Working Group on Accreditation and ISO/CEN standards provides here a proposal on retention periods of documentation and specimens based on a failure-mode-effects-analysis (FMEA) risk-based approach, a concept of risk reduction that has become an integral part of modern standards.


  • Open Access

    Validation and verification of examination procedures in medical laboratories: opinion of the EFLM Working Group Accreditation and ISO/CEN standards (WG-A/ISO) on dealing with ISO 15189:2012 demands for method verification and validation

    by Roseri Roelofsen-De Beer, Jos Wielders, Guilaine Boursier, Tatjana Vodnik, Florent Vanstapel, Willem Huisman, Ines Vukasović, Michel Vaubourdolle, Çiğdem Sönmez, Solveig Linko, et al.

    This paper reflects the opinion of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group Accreditation and ISO/CEN standards (WG-A/ISO). It aims to provide guidance for drawing up local/national documents about validation and verification of laboratory methods. We demonstrate how risk evaluation can be used to optimize laboratory policies to meet intended use requirements as well as requirements of standards. This is translated in a number of recommendations on how to introduce risk evaluation in various stages of the implementation of new methods ultimately covering the whole process cycle.


  • Documenting metrological traceability as intended by ISO 15189:2012: A consensus statement about the practice of the implementation and auditing of this norm element

    by Marc Thelen, Florent Vanstapel, Pika Meško Brguljan, Bernard Gouget, Guilaine Boursier, Edward Barrett, Christos Kroupis, Maria Lohmander, Luděk Šprongl, Tatjana Vodnik, et al.

    ISO15189:2012 requires medical laboratories to document metrological traceability of their results. While the ISO17511:2003 standard on metrological traceability in laboratory medicine requires the use of the highest available level in the traceability chain, it recognizes that for many measurands there is no reference above the manufacturer’s selected measurement procedure and the manufacturer’s working calibrator. Some immunoassays, although they intend to measure the same quantity and may even refer to the same reference material, unfortunately produce different results because of differences in analytical selectivity as manufacturers select different epitopes and antibodies for the same analyte. In other cases, the cause is the use of reference materials, which are not commutable. The uncertainty associated with the result is another important aspect in metrological traceability implementation. As the measurement uncertainty on the clinical samples is influenced by the uncertainty of all steps higher in the traceability chain, laboratories should be provided with adequate and appropriate information on the uncertainty of the value assignment to the commercial calibrators that they use. Although the between-lot variation in value assignment will manifest itself as part of the long-term imprecision as estimated by the end-user, information on worst-case to be expected lot-lot variation has to be communicated to the end-user by the IVD provider. When laboratories use ancillary equipment that potentially could have a critical contribution to the reported results, such equipment needs verification of its proper calibration and criticality to the result uncertainty could be assessed by an approach based on risk analysis, which is a key element of ISO15189:2012 anyway. This paper discusses how the requirement for metrological traceability as stated in ISO15189 should be met by the medical laboratory and how this should be assessed by accreditation bodies.